Zurich Insurance Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.8M Buy
+458,174
New +$35.8M 0.28% 85
2022
Q4
Sell
-363,800
Closed -$30.1M 230
2022
Q3
$30.1M Buy
363,800
+30,171
+9% +$2.49M 0.47% 73
2022
Q2
$31.7M Sell
333,629
-172,770
-34% -$16.4M 0.47% 77
2022
Q1
$59.6M Sell
506,399
-148,337
-23% -$17.5M 0.74% 49
2021
Q4
$84.8M Buy
654,736
+442,786
+209% +$57.4M 0.96% 37
2021
Q3
$24M Buy
211,950
+4,689
+2% +$531K 0.29% 70
2021
Q2
$21.5M Buy
+207,261
New +$21.5M 0.27% 68
2021
Q1
Sell
-1,213,369
Closed -$111M 213
2020
Q4
$111M Buy
1,213,369
+357,407
+42% +$32.6M 1.63% 26
2020
Q3
$68.3M Buy
855,962
+380,455
+80% +$30.4M 1.18% 34
2020
Q2
$32.9M Buy
475,507
+132,175
+38% +$9.13M 0.56% 46
2020
Q1
$21.6M Buy
+343,332
New +$21.6M 0.46% 54
2019
Q4
Sell
-107,967
Closed -$7.91M 318
2019
Q3
$7.91M Buy
107,967
+3,573
+3% +$262K 0.15% 171
2019
Q2
$6.43M Buy
104,394
+4,095
+4% +$252K 0.13% 207
2019
Q1
$6.4M Buy
+100,299
New +$6.4M 0.14% 199
2018
Q3
Sell
-153,888
Closed -$7.47M 475
2018
Q2
$7.47M Sell
153,888
-1,167
-0.8% -$56.6K 0.17% 176
2018
Q1
$7.21M Buy
155,055
+33,102
+27% +$1.54M 0.17% 171
2017
Q4
$4.58M Buy
121,953
+76,677
+169% +$2.88M 0.11% 228
2017
Q3
$1.65M Sell
45,276
-88,911
-66% -$3.24M 0.05% 424
2017
Q2
$5.29M Buy
134,187
+28,683
+27% +$1.13M 0.15% 162
2017
Q1
$3.31M Sell
105,504
-51,831
-33% -$1.63M 0.1% 255
2016
Q4
$4.91M Sell
157,335
-15,216
-9% -$475K 0.16% 167
2016
Q3
$6.93M Buy
172,551
+92,289
+115% +$3.71M 0.23% 114
2016
Q2
$2.67M Sell
80,262
-84,246
-51% -$2.8M 0.09% 236
2016
Q1
$4.84M Sell
164,508
-255,042
-61% -$7.5M 0.17% 161
2015
Q4
$11M Sell
419,550
-49,110
-10% -$1.29M 0.4% 76
2015
Q3
$11.1M Buy
+468,660
New +$11.1M 0.41% 90